| Hang Seng Index | 22.720 HKD | +0.060 | +0.265% | 41.30M | 935.75M | 23.260 (-2.321%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 84.260 HKD | -0.320 | -0.378% | 10.36M | 870.92M | 86.975 (-3.122%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.025 HKD | -0.055 | -1.083% | 63.43M | 318.41M | 6.590 (-23.748%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.846 HKD | +0.022 | +1.206% | 117.74M | 217.75M | 1.831 (+0.797%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.115 HKD | -0.025 | -0.486% | 27.43M | 140.05M | 5.580 (-8.337%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.600 HKD | -0.012 | -0.459% | 21.17M | 55.27M | 2.726 (-4.619%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 10.970 HKD | -0.080 | -0.724% | 3.94M | 43.17M | 12.133 (-9.583%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 4.614 HKD | +0.024 | +0.523% | 9.00M | 41.36M | 5.000 (-7.714%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.185 HKD | -0.025 | -0.480% | 5.23M | 27.19M | 5.659 (-8.368%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 2,410.000 HKD | +80.000 | +3.433% | 7.21K | 17.34M | N/A | | |
| CSI 300 | 42.060 HKD | -0.200 | -0.473% | 199.80K | 8.40M | 43.473 (-3.251%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.570 HKD | +1.100 | +6.679% | 415.70K | 7.27M | 13.980 (+25.683%) HKD as at 2025/02/24 | | |
| Hang Seng High Dividend Yield | 24.660 HKD | 0.000 | 0.000% | 242.20K | 5.97M | 24.714 (-0.219%) HKD as at 2025/02/24 | | |
| Hang Seng Index (net total return version) | 82.580 HKD | +0.200 | +0.243% | 59.30K | 4.89M | 84.732 (-2.540%) HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.190 HKD | -0.045 | -0.860% | 832.40K | 4.32M | 4.925 (+5.374%) HKD as at 2025/02/24 | | |
| FTSE China A50 | 13.490 HKD | -0.090 | -0.663% | 254.60K | 3.43M | 13.749 (-1.884%) HKD as at 2025/02/24 | | |
| MSCI Japan 100% Hedged to USD Index | 20.740 HKD | +0.260 | +1.270% | 143.60K | 2.98M | 21.175 (-2.055%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 3.086 HKD | -0.002 | -0.065% | 897.50K | 2.76M | 4.284 (-27.968%) HKD as at 2025/02/24 | | |
| Hang Seng TECH Index | 6.625 HKD | -0.030 | -0.451% | 406.40K | 2.69M | 7.219 (-8.231%) HKD as at 2025/02/25 | | |
| MSCI Taiwan | 213.400 HKD | +3.000 | +1.426% | 12.30K | 2.62M | 223.479 (-4.510%) HKD as at 2025/02/24 | | |
| FTSE China A50 | 12.570 HKD | -0.070 | -0.554% | 167.00K | 2.11M | 12.681 (-0.878%) HKD as at 2025/02/25 | | |
| FTSE US Treasury 20+ Years Index | 67.420 HKD | -1.560 | -2.262% | 26.21K | 1.77M | 70.043 (-3.745%) HKD as at 2025/02/24 | | |
| Hang Seng China Enterprises | 10.200 HKD | 0.000 | 0.000% | 161.50K | 1.65M | 10.808 (-5.628%) HKD as at 2025/02/24 | | |
| CSI 300 | 39.220 CNY | -0.300 | -0.759% | 41.20K | 1.62M | 40.598 (-3.395%) CNY as at 2025/02/25 | | |
| S&P GSCI Crude Oil Index Excess Return | 5.730 HKD | -0.085 | -1.462% | 257.40K | 1.47M | 6.880 (-16.709%) HKD as at 2025/02/24 | | |
| London Gold Fixing Price | 79.000 HKD | +2.500 | +3.268% | 17.20K | 1.36M | 69.203 (+14.157%) HKD as at 2025/02/25 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 4.054 HKD | -0.012 | -0.295% | 333.30K | 1.35M | 4.098 (-1.083%) HKD as at 2025/02/25 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 11.560 HKD | -0.270 | -2.282% | 104.00K | 1.20M | 11.063 (+4.494%) HKD as at 2025/02/25 | | |
| Bloomberg Barclays US Treasury Floating Rate Bond Index | 3,933.550 HKD | -0.950 | -0.024% | 300.00 | 1.18M | 3,911.593 (+0.561%) HKD as at 2025/02/24 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 11.500 HKD | -0.080 | -0.691% | 98.50K | 1.14M | 10.297 (+11.681%) HKD as at 2025/02/25 | | |